Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Sr. Vice President | February 25, 2021 | March 01, 2021 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | May 22, 2026 | May 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
THERMO FISHER SCIENTIFIC INC.
Report date February 25, 2021 · Filed March 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,349 |
Ending reported balance
After 2021-02-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-02-25 · Tax withholding · Disposed 790 · Balance 23,488 Row 2 · 2021-02-26 · Tax withholding · Disposed 1,139 · Balance 22,349 |
| Common StockSEC Table I · non-derivative | Indirectby 401K | 41.32 |
Reported balance
Holding disclosure · report date 2021-02-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 41.32 |
ZIMMER BIOMET HOLDINGS, INC.
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $85.68 | Direct | 8,288.638 |
Reported balance
After 2026-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 875.35 · Balance 8,288.638 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director F4: Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,098 |
Reported balance
After 2026-05-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-22 · Grant · Acquired 1,517.274 · Balance 9,098 F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director
F4: Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 4,100 | $253.99 | $1,041,359.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 10 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 700 | $415.15 | $290,605.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 9 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,019 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.06 to $415.29, inclusive. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,875 | $414.17 | $1,604,908.75 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 8 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,719 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.74 to $414.545, inclusive. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 4,575 | $210.68 | $963,861.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 7 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 6,200 | $415.76 | $2,577,712.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 6 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,019 Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 6,200 | $157.68 | $977,616.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 5 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 313 | $415.88 | $130,170.44 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 4 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,019 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.86 to $416.17, inclusive. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,225 | $415.44 | $1,339,794.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 3 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,332 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.84 to $415.815, inclusive. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 2,100 | $414.32 | $870,072.00 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 2 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,557 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.785 to $414.66, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), and (6) to this Form 4. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:09 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 5,638 | $129.77 | $731,643.26 |
DisclosureSEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 1 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 116.152 | $0.00 Strike: $118.38 | $0.00 |
DisclosureSEC source: 0000911916-20-000163 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843.18 Underlying: Common Stock · 116.152 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,077.229 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000106 · edgar.xml · derivative · entry 2 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,155.351 Underlying: Common Stock · 1,077.229 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.68 | $0.00 |
DisclosureSEC source: 0000911916-20-000106 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,727.028 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 2.161 phantom stock units accrued on April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 138.861 | $0.00 Strike: $99.02 | $0.00 |
DisclosureSEC source: 0000911916-20-000094 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,224.867 Underlying: Common Stock · 138.861 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 1.596 phantom stock units accrued on January 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:28 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,154 | $297.08 | $342,830.32 |
DisclosureSEC source: 0001127602-20-008371 · form4.xml · nonDerivative · entry 1 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,019 Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:54 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 957 | $309.16 | $295,866.12 |
DisclosureSEC source: 0001127602-20-008155 · form4.xml · nonDerivative · entry 4 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,173 Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:54 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 11,450 | $0.00 Strike: $309.63 | $0.00 |
DisclosureSEC source: 0001127602-20-008155 · form4.xml · derivative · entry 6 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,450 Underlying: Common Stock · 11,450 shares Expires 2027-02-25 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 25, 2021. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:54 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 582 | $309.63 | $180,204.66 |
DisclosureSEC source: 0001127602-20-008155 · form4.xml · nonDerivative · entry 3 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,130 Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:54 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 5,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008155 · form4.xml · nonDerivative · entry 2 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,712 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 26, 2019. The Company's Compensation Committee determined on February 25, 2020, that the performance criteria related to this award was satisfied. One-third of the shares vested on February 25, 2020, one-third of the shares vest on February 25, 2021, and the remaining one-third vest on February 25, 2022. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:54 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 2,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008155 · form4.xml · nonDerivative · entry 1 Jafry Syed A. · CIK 0001745891 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,762 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:45 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 92.282 | $0.00 Strike: $149.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000012 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,084.41 Underlying: Common Stock · 92.282 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 1.726 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:38 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 87.233 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000175 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990.402 Underlying: Common Stock · 87.233 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 1.421 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 102.081 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000141 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901.748 Underlying: Common Stock · 102.081 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:27 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000116 · edgar.xml · derivative · entry 2 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078.122 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:27 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000116 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799.667 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.405 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 21:28 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 93.335 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000094 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299.262 Underlying: Common Stock · 93.335 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes .201 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 1,925 | $125.52 | $241,623.88 |
DisclosureSEC source: 0000911916-19-000068 · edgar.xml · nonDerivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:20 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 114.834 | $0.00 Strike: $103.41 | $0.00 |
DisclosureSEC source: 0000911916-19-000008 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205.726 Underlying: Common Stock · 114.834 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 20:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 90.892 | $0.00 Strike: $130.65 | $0.00 |
DisclosureSEC source: 0000911916-18-000182 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90.892 Underlying: Common Stock · 90.892 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.